Thursday, November 20, 2008 - 4:14PM EST

Clinical Trials

71. Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.

Author
Wang LR; Huang MZ; Zhang GB; Xu N; Wu XH;
Institution
Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, People's Republic of China.
Journal
Cancer Chemother Pharmacol. 2007 Sep;60(4):601-7. Epub 2007 Jun 5.
Abstract URL
Click here to view abstract

72. Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.

Author
Weiss GJ; Vokes EE; Bunn PA Jr; Magree L; Rusk J; Albert D; Kelly K;
Institution
TGen Clinical Research Services at Scottsdale Healthcare, Scottsdale, AZ, USA.
Journal
J Thorac Oncol. 2007 Oct;2(10):933-8.
Abstract URL
Click here to view abstract

73. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.

Author
Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV;
Institution
Department of Radiation Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. j.belderbos@nki.nl
Journal
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):126-34.
Abstract URL
Click here to view abstract

74. Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.

Author
Hanna N; Lilenbaum R; Ansari R; Lynch T; Govindan R; Janne PA; Bonomi P;
Institution
Indiana University, Indianapolis, USA. nhanna@iupui.edu
Journal
J Clin Oncol. 2006 Nov 20;24(33):5253-8.
Abstract URL
Click here to view abstract

75. Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer.

Author
Akerley W; Safran H; Zaner K; Ready N; Mega T; Kennedy T; Akerley W; Safran H; Zaner K; Ready N; Mega T; Kennedy T;
Institution
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84115, USA. akerley@HCI.utah.edu
Journal
Cancer. 2006 Sep 1;107(5):1050-4.
Abstract URL
Click here to view abstract

76. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.

Author
Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI; Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI;
Institution
Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom. arc@macunlimited.net
Journal
Cancer. 2006 Sep 15;107(6):1321-30.
Abstract URL
Click here to view abstract

77. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Author
Olaussen KA; Dunant A; Fouret P; Brambilla E; Andre F; Haddad V; Taranchon E; Filipits M; Pirker R; Popper HH; Stahel R; Sabatier L; Pignon JP; Tursz T; Le Chevalier T; Soria JC; Olaussen KA; Dunant A; Fouret P; Brambilla E; Andre F; Haddad V; Taranchon E; Filipits M; Pirker R; Popper HH; Stahel R; Sabatier L; Pignon JP; Tursz T; Le Chevalier T; Soria JC;
Institution
Laboratory of Radiobiology and Oncology, Commissariat a l'Energie Atomique, Fontenay aux Roses, University of Paris 11, Paris, France.
Journal
N Engl J Med. 2006 Sep 7;355(10):983-91.
Abstract URL
Click here to view abstract

78. Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases.

Author
Rogers LR; Rock JP; Sills AK; Vogelbaum MA; Suh JH; Ellis TL; Stieber VW; Asher AL; Fraser RW; Billingsley JS; Lewis P; Schellingerhout D; Shaw EG; Rogers LR; Rock JP; Sills AK; Vogelbaum MA; Suh JH; Ellis TL; Stieber VW; Asher AL; Fraser RW; Billingsley JS; Lewis P; Schellingerhout D; Shaw EG;
Institution
Department of Neurology and Neurosurgery, Henry Ford Hospital, Detroit, Michigan 48109-0316, USA. lisaroge@umich.edu
Journal
J Neurosurg. 2006 Sep;105(3):375-84.
Abstract URL
Click here to view abstract

79. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study.

Author
Okada M; Koike T; Higashiyama M; Yamato Y; Kodama K; Tsubota N; Okada M; Koike T; Higashiyama M; Yamato Y; Kodama K; Tsubota N;
Institution
Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan. morihito1217jp@aol.com
Journal
J Thorac Cardiovasc Surg. 2006 Oct;132(4):769-75.
Abstract URL
Click here to view abstract

80. A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer.

Author
Milton DT; Azzoli CG; Heelan RT; Venkatraman E; Gomez JE; Kris MG; Krug LM; Pao W; Rizvi NA; Dunne M; Miller VA; Milton DT; Azzoli CG; Heelan RT; Venkatraman E; Gomez JE; Kris MG; Krug LM; Pao W; Rizvi NA; Dunne M; Miller VA;
Institution
Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and the Weill Medical College of Cornell University, New York, New York 10021, USA.
Journal
Cancer. 2006 Sep 1;107(5):1034-41.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9 10 11 12